James E. Galagan
- Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology 18
- Molecular Medicine top 1%
- Epidemiology top 1%
- Mycobacterium research and diagnosis 15
- Molecular Biology top 2%
- RNA and protein synthesis mechanisms 19
- Genomics and Phylogenetic Studies 14
- Advanced biosensing and bioanalysis techniques 10
- Microbial Metabolic Engineering and Bioproduction 7
- RNA Research and Splicing 7
- Endocrinology top 2%
-
- Bacterial Genetics and Biotechnology 10
- Co-authors
- Eric U. SelkerBruce W. BirrenSébastien GagneuxStefan NiemannIñaki ComasDaniel E. NeafseyKristin KremerPeter M. Small
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
James E. Galagan
74 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Infectious Diseases 1.8k
- Molecular Medicine 470
- Epidemiology 1.8k
- Molecular Biology 3.4k
- Endocrinology 215
Countries citing papers authored by James E. Galagan
This map shows the geographic impact of James E. Galagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Galagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Galagan more than expected).
Fields of papers citing papers by James E. Galagan
This network shows the impact of papers produced by James E. Galagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Galagan. The network helps show where James E. Galagan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James E. Galagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 17 | |
| 2 | 2022 | 9 | |
| 3 | 2022 | 14 | |
| 4 | 2020 | 65 | |
| 5 | 2020 | 28 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 93 | |
| 8 | 2018 | 242 | |
| 9 | 2016 | 101 | |
| 10 | 2016 | 34 | |
| 11 | 2015 | 22 | |
| 12 | 2013 | 51 | |
| 13 | 2013 | 92 | |
| 14 | Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genesbreakdown → | 2011 | 410 |
| 15 | 2008 | 375 | |
| 16 | 2007 | 20 | |
| 17 | 2006 | 2 | |
| 18 | 2005 | 222 | |
| 19 | 2005 | 134 | |
| 20 | 1985 | 54 |
About James E. Galagan
James E. Galagan is a scholar working on Infectious Diseases, Molecular Biology, Endocrinology, Genetics and Molecular Medicine, having authored 76 papers that have together received 6.0k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (19 papers), Tuberculosis Research and Epidemiology (18 papers), Mycobacterium research and diagnosis (15 papers), Genomics and Phylogenetic Studies (14 papers), Advanced biosensing and bioanalysis techniques (10 papers), Bacterial Genetics and Biotechnology (10 papers), Microbial Metabolic Engineering and Bioproduction (7 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Molecular Medicine (470 citations), Epidemiology (1.8k citations), Molecular Biology (3.4k citations) and Endocrinology (215 citations). James E. Galagan has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Eric U. Selker, Bruce W. Birren, Sébastien Gagneux, Stefan Niemann, Iñaki Comas, Daniel E. Neafsey, Kristin Kremer, Peter M. Small, Aaron Brandes and J. Ernst. Their work appears in journals such as PLoS ONE, Nucleic Acids Research, Genome Research, Nature Communications and Genome biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.